Spatial technologies to evaluate the HIV-1 reservoir and its microenvironment in the lymph node.

HIV-1 HIV-1 reservoir human immunodeficiency virus lymph node spatial technologies tfh

Journal

mBio
ISSN: 2150-7511
Titre abrégé: mBio
Pays: United States
ID NLM: 101519231

Informations de publication

Date de publication:
26 Jul 2024
Historique:
medline: 26 7 2024
pubmed: 26 7 2024
entrez: 26 7 2024
Statut: aheadofprint

Résumé

The presence of the HIV-1 reservoir, a group of immune cells that contain intact, integrated, and replication-competent proviruses, is a major challenge to cure HIV-1. HIV-1 reservoir cells are largely unaffected by the cytopathic effects of viruses, antiviral immune responses, or antiretroviral therapy (ART). The HIV-1 reservoir is seeded early during HIV-1 infection and augmented during active viral replication. CD4+ T cells are the primary target for HIV-1 infection, and recent studies suggest that memory T follicular helper cells within the lymph node, more precisely in the B cell follicle, harbor integrated provirus, which contribute to viral rebound upon ART discontinuation. The B cell follicle, more specifically the germinal center, possesses a unique environment because of its distinct property of being partly immune privileged, potentially allowing HIV-1-infected cells within the lymph nodes to be protected from CD8+ T cells. This modified immune response in the germinal center of the follicle is potentially explained by the exclusion of CD8+ T cells and the presence of T regulatory cells at the junction of the follicle and extrafollicular region. The proviral makeup of HIV-1-infected cells is similar in lymph nodes and blood, suggesting trafficking between these compartments. Little is known about the cell-to-cell interactions, microenvironment of HIV-1-infected cells in the follicle, and trafficking between the lymph node follicle and other body compartments. Applying a spatiotemporal approach that integrates genomics, transcriptomics, and proteomics to investigate the HIV-1 reservoir and its neighboring cells in the lymph node has promising potential for informing HIV-1 cure efforts.

Identifiants

pubmed: 39058091
doi: 10.1128/mbio.01909-24
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0190924

Auteurs

Fatima Zaman (F)

Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Melissa L Smith (ML)

Department of Biochemistry and Molecular Genetics, University of Louisville School of Medicine, Louisville, Kentucky, USA.

Ashwin Balagopal (A)

Division of Infectious Diseases, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.

Christine M Durand (CM)

Division of Infectious Diseases, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.

Andrew D Redd (AD)

Division of Infectious Diseases, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.

Aaron A R Tobian (AAR)

Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Division of Infectious Diseases, Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.

Classifications MeSH